Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• Coronaviruses (CoVs) cause a spectrum of illnesses, from common colds to severe diseases like SARS, MERS, and COVID-19.
• The high infectivity and pathogenicity of SARS-CoV, MERS-CoV, and SARS-CoV-2 pose significant global health threats.
• Currently, no specific treatments are proven effective against these viral infections, underscoring the need for preventive measures.

Purpose of the Study:

• To review coronavirus vaccine design targets.
• To summarize recent progress in the development of coronavirus vaccines.
• To highlight adjuvants that can improve the efficacy of coronavirus vaccines.

Main Methods:

• Literature review of scientific publications on coronavirus vaccines.
• Analysis of vaccine design strategies targeting CoVs.
• Summary of current research on vaccine adjuvants.

Main Results:

• Vaccination remains a primary strategy for preventing viral infections.
• Significant research is underway to develop effective vaccines against pathogenic coronaviruses.
• Adjuvants play a key role in enhancing the immune response to vaccines.

Conclusions:

• Effective vaccines are essential to combat the threat of highly pathogenic coronaviruses.
• Continued research into vaccine design, development, and adjuvant use is critical.
• Advancements in vaccinology offer promising strategies to control coronavirus outbreaks.